Bioavailability enhancement

Bioavailability enhancement Companies (8)

Bioavailability enhancement News

Bioavailability enhancement Products (11)

  • Product Bioavailability Enhancement - Oral Drug Products and Intermediates

    The depth of our bioavailability (BA) enhancement offering makes us a leader in addressing addressing low solubility, low bioavailability and dissolution rate issues. We work collaboratively with our customers to advance compounds, or re-purpose existing compounds, across a full range of API properties and...
  • Product Inhalation Formulation Services

    Inhaled drug products for nasal or pulmonary delivery continue in popularity due to the prevalence of respiratory diseases around the globe. Additionally, the lung’s absorptive capacity continues to be explored as an attractive delivery point for both local and systemic applications. Particle engineering, ...
  • Product Recombinant Human Hyaluronidase Injection

    Hyaluronidase, an enzyme that breaks down hyaluronic acid, has long been used to facilitate the dispersion and absorption of other drugs and to reduce tissue damage in cases of extravasation of a drug. Recombinant human hyaluronidase (rhPH20) developed by BaoPharma is the only...
  • Product Cavitron™ cyclodextrins (hydroxypropyl betacyclodextrin)

    cavitron™ cyclodextrins (hydroxypropyl betacyclodextrin) are the perfect substances for increasing solubility and enhancing bioavailability. They are manufactured to high purity standards for low bioburden and endotoxin.
    To learn more visit
  • Product Dispersome® Technology

    Dispersome®️ – A green technology for drugs

    The Dispersome® technology uses high quality whey protein, an environmentally friendly by-product from cheese production, to improve the solubility and bioavailability of poorly soluble drugs.

    To watch explanatory Dispersome...
  • Product Poor Solubility & Bioavailability Enhancement

    With nearly 30 years of experience, Quotient has established a broad suite of technologies and formulation approaches to address these complex solubility challenges. Our approach allows us to dramatically speed up the optimization of your drug products to improve oral bioavailability. For more information ...
  • Product Solid Form Services

    The selection of a lead solid form of an API is a critical step in early pharmaceutical development. Determining the most suitable chemical and physical form impacts a range of critical parameters including manufacturability, stability and bioavailability. The selection of a lead solid involves the screeni...
  • Product KinetiSol Technology

    The KinetiSol Technology generates amorphous solid dispersions, dramatically improving the bioavailability of poorly soluble drugs. KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies, in a fraction of the time of other ASD technologies. With its significantly smal...
  • Product NanaBidial™

    NanaBidial™ is an investigative new product containing 20 mg/mL of Cannabidiol (CBD) and and <1mg/mL of delta-9-tetrahydrocannabinol (THC), in a sub-micron spray applied to the oro-buccal membrane.
    The buccal administration of a NanoCelle™ CBD preparation to healthy volunteers:...
  • Product MultiBiotic™

    MultiBiotic™ is an evidence-based multi-species probiotic specifically designed to target end-organ function and support gastrointestinal health and maintenance. MultiBiotic™ is an ARTG listed medicine and available in Pharmacies and HCP's in AU, NZ, SG and HK. Presently MultiBiotic™ is in Phase ...
  • Product NanoCBD

    NanoCBD is a formulation containing 16.67 mg/mL cannabidiol (CBD) as active ingredient, in a sub-micron spray applied to the oro-buccal membrane. The CBD is sourced from cannabis (hemp) strains and extracted from plant parts that produce high levels of CBD, but no THC.


Upcoming Events

  • CPHI & PMEC China 2024

    Shanghai New International Expo Center
    19 June 2024 - 21 June 2024
  • CPHI South East Asia 2024

    Queen Sirikit National Convention Center, Bangkok, Thailand
    10 Jul 2024 - 12 Jul 2024
  • CPHI Korea 2024

    COEX, Seoul, Korea
    27 Aug 2024 - 29 Aug 2024

Pharmaceutical Industry Webinars